$GLAI
Global AI, Inc.

2024 Q2 Form 10-Q Financial Statement

#000149315224020400 Filed on May 17, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $346.2K $524.2K
YoY Change 1815.88% 3010.98%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $263.8K $346.2K $524.2K
YoY Change 1482.4% 1815.83% 3011.35%
Operating Profit -$263.8K -$346.2K
YoY Change 12036.57% 32225.86%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$346.2K -$524.2K
YoY Change 17123.88% 18554.8%
Income Tax
% Of Pretax Income
Net Earnings -$263.8K -$346.2K -$524.2K
YoY Change 4335.18% 17107.26% 18554.8%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 154.3M shares 154.3M shares
Diluted Shares Outstanding 154.3M shares 154.3M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.70K $184.0K
YoY Change 341.51% 1928.67%
Cash & Equivalents $22.42K $11.70K $184.0K
Short-Term Investments
Other Short-Term Assets $1.100K $1.100K
YoY Change -79.32% -13.39%
Inventory
Prepaid Expenses $1.095K $1.095K $1.095K
Receivables
Other Receivables
Total Short-Term Assets $23.51K $12.80K $185.1K
YoY Change 117.72% -1.36% 1106.07%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $23.51K $12.80K $185.1K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $23.51K $12.80K $185.1K
YoY Change 106.66% -5.57% 1062.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $103.7K $201.9K $232.1K
YoY Change 17753.0%
Accrued Expenses $9.200K $5.100K
YoY Change -11.62% -46.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.4K $211.1K $237.2K
YoY Change 3.75% 101.98% 126.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $112.4K $211.1K $237.2K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $112.4K $211.1K $237.2K
YoY Change 3.75% 101.98% 126.13%
SHAREHOLDERS EQUITY
Retained Earnings -$2.661M -$2.398M -$2.051M
YoY Change 87.17% 69.33% 45.08%
Common Stock $154.3K $154.3K $154.3K
YoY Change 473.18% 473.32% 473.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$88.85K -$198.3K -$52.13K
YoY Change
Total Liabilities & Shareholders Equity $23.51K $12.80K $185.1K
YoY Change 106.66% -5.57% 1062.28%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$263.8K -$346.2K -$524.2K
YoY Change 4335.18% 17107.26% 18554.8%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$372.3K -$316.0K
YoY Change 5698.49% -9787.31%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $200.0K $0.00
YoY Change
Cash From Investing Activities $200.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K
YoY Change
NET CHANGE
Cash From Operating Activities -$372.3K -316.0K
Cash From Investing Activities $200.0K 0.000
Cash From Financing Activities 500.0K
Net Change In Cash -$172.3K 184.0K
YoY Change 2583.22% 5540.71%
FREE CASH FLOW
Cash From Operating Activities -$372.3K -$316.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 WSCO Contracted Servicesrelated Party
ContractedServicesrelatedParty
usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
CY2024Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2023Q1 WSCO Proceeds From Funds Received From Subscription Receivable
ProceedsFromFundsReceivedFromSubscriptionReceivable
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154312024 shares
CY2024Q1 us-gaap Cash
Cash
11701 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1095 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
12796 usd
CY2024Q1 us-gaap Assets
Assets
12796 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
201911 usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
9225 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
211136 usd
CY2024Q1 us-gaap Liabilities
Liabilities
211136 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154348024 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154348024 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154348024 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154348024 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
154348 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2044915 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2397603 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-198340 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12796 usd
CY2023Q1 WSCO Contracted Servicesrelated Party
ContractedServicesrelatedParty
17000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
148108 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6758 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
198102 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
11313 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
346210 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
18071 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-346210 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1071 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
941 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-941 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-346210 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2012 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154348024 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154348024 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107688024 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107688024 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-88970 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2012 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-90982 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-52130 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-52130 usd
CY2024Q1 WSCO Adjustments To Additional Paid In Capital Cash Received From Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromSubscriptionReceivable
200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-346210 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-198340 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-198340 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-346210 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2012 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6312 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-30178 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4125 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1903 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-372263 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6421 usd
CY2024Q1 WSCO Proceeds From Funds Received From Subscription Receivable
ProceedsFromFundsReceivedFromSubscriptionReceivable
200000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
200000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-172263 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6421 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
183964 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9074 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11701 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2653 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zYgPcJMhe2W8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zclb0VVomVxb">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are prepared in accordance with Accounting Principles Generally Accepted in the United States (“GAAP”). These accounting principles require the Company to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. The financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. Significant estimates include the valuation allowance on deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-346210 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
372263 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154348024 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154348024 shares
CY2024Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
4-for-1 forward stock split
CY2024Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 integer

Files In Submission

Name View Source Status
0001493152-24-020400-index-headers.html Edgar Link pending
0001493152-24-020400-index.html Edgar Link pending
0001493152-24-020400.txt Edgar Link pending
0001493152-24-020400-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wsco-20240331.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wsco-20240331_lab.xml Edgar Link unprocessable
wsco-20240331_cal.xml Edgar Link unprocessable
wsco-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
wsco-20240331_def.xml Edgar Link unprocessable